Supernormal Antithrombin Activity Is an Independent Predictor of In-Hospital Mortality in Patients With Sepsis: A Retrospective Observational Study

被引:5
作者
Azuhata, Takeo [1 ,2 ]
Hayakwa, Mineji [3 ]
Maekawa, Kunihiko [3 ]
Komatsu, Tomohide [1 ]
Kuwana, Tsukasa [1 ]
Kawano, Daisuke [1 ,2 ]
Nakamura, Kazuhiro [1 ,2 ]
Kinoshita, Kosaku [1 ]
Wada, Takeshi [3 ]
Tanjoh, Katsuhisa [1 ,2 ]
机构
[1] Nihon Univ, Sch Med, Dept Acute Med, Div Emergency & Crit Care Med, Tokyo, Japan
[2] Seitokai Azuhata Hosp, Dept Gen & Acute Med, Ibaraki, Japan
[3] Hokkaido Univ Hosp, Dept Emergency Med, Sapporo, Hokkaido, Japan
关键词
antithrombin; disseminated intravascular coagulation; mortality; prognosis; sepsis; DISSEMINATED INTRAVASCULAR COAGULATION; SEPTIC SHOCK; SUPPLEMENTATION;
D O I
10.1177/1076029620912827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Supernormal antithrombin (AT) activity is rare in patients with sepsis. This study compared mortality rate of patients with sepsis and supernormal AT activity with that of other patients. This retrospective study included patients with sepsis from 42 intensive care units (ICUs) in Japan. Patients were included if their AT activity was measured on ICU admission, and if they did not receive AT concentrate. They were categorized into low, normal, and supernormal with respective AT activity of <= 70%, >70% to <= 100%, and >100%. The primary outcome was hospital in-patient mortality. Nonlinear regression analysis showed that mortality risk gradually increased with AT activity in the supernormal range, but without statistical significance. Survival rate was significantly lower in low (67%) and supernormal (57%) AT groups than in the normal AT group (79%; P < .001 and P = .008, respectively). After adjusting for disease severity and AT activity on day 2, supernormal AT activity was the only independent predictor of mortality. Sepsis with supernormal AT activity associated with high mortality, independent of disease severity, might be a predictor of in-hospital mortality.
引用
收藏
页数:7
相关论文
共 21 条
  • [1] Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation
    Aibiki, Mayuki
    Fukuoka, Noriyasu
    Umakoshi, Kensuke
    Ohtsubo, Saori
    Kikuchi, Satoshi
    [J]. SHOCK, 2007, 27 (02): : 139 - 144
  • [2] Severe Sepsis and Septic Shock
    Moreira, Jose
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21) : 2063 - 2063
  • [3] SEPTIC SHOCK, MULTIPLE ORGAN FAILURE, AND DISSEMINATED INTRAVASCULAR COAGULATION - COMPARED PATTERNS OF ANTITHROMBIN-III, PROTEIN-C, AND PROTEIN-S DEFICIENCIES
    FOURRIER, F
    CHOPIN, C
    GOUDEMAND, J
    HENDRYCX, S
    CARON, C
    RIME, A
    MAREY, A
    LESTAVEL, P
    [J]. CHEST, 1992, 101 (03) : 816 - 823
  • [4] Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1
  • [5] THE RESPONSE OF ANTITHROMBIN III ACTIVITY AFTER SUPPLEMENTATION DECREASES IN PROPORTION TO THE SEVERITY OF SEPSIS AND LIVER DYSFUNCTION
    Hayakawa, Mineji
    Sawamura, Atsushi
    Yanagida, Yuichiro
    Sugano, Masahiro
    Hoshino, Hirokatsu
    Gando, Satoshi
    [J]. SHOCK, 2008, 30 (06): : 649 - 652
  • [6] Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011-2013
    Hayakawa, Mineji
    Yamakawa, Kazuma
    Saito, Shinjiro
    Uchino, Shigehiko
    Kudo, Daisuke
    Iizuka, Yusuke
    Sanui, Masamitsu
    Takimoto, Kohei
    Mayumi, Toshihiko
    [J]. SCIENTIFIC DATA, 2018, 5
  • [7] Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study
    Hayakawa, Mineji
    Yamakawa, Kazuma
    Kudo, Daisuke
    Ono, Kota
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (06) : 874 - 883
  • [8] ANTITHROMBIN SUPPLEMENTATION AND MORTALITY IN SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY
    Hayakawa, Mineji
    Kudo, Daisuke
    Saito, Shinjiro
    Uchino, Shigehiko
    Yamakawa, Kazuma
    Iizuka, Yusuke
    Sanui, Masamitsu
    Takimoto, Kohei
    Mayumi, Toshihiko
    Ono, Kota
    Azuhata, Takeo
    Ito, Fumihito
    Yoshihiro, Shodai
    Hayakawa, Katsura
    Nakashima, Tsuyoshi
    Ogura, Takayuki
    Noda, Eiichiro
    Nakamura, Yoshihiko
    Sekine, Ryosuke
    Yoshikawa, Yoshiaki
    Sekino, Motohiro
    Ueno, Keiko
    Okuda, Yuko
    Watanabe, Masayuki
    Tampo, Akihito
    Saito, Nobuyuki
    Kitai, Yuya
    Takahashi, Hiroki
    Kobayashi, Iwao
    Kondo, Yutaka
    Matsunaga, Wataru
    Nachi, Sho
    Miike, Toru
    Takahashi, Hiroshi
    Takauji, Shuhei
    Umakoshi, Kensuke
    Todaka, Takafumi
    Kodaira, Hiroshi
    Andoh, Kohkichi
    Kasai, Takehiko
    Iwashita, Yoshiaki
    Arai, Hideaki
    Murata, Masato
    Yamane, Masahiro
    Shiga, Kazuhiro
    Hori, Naoto
    [J]. SHOCK, 2016, 46 (06): : 623 - 631
  • [9] Hayakawa M, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0169-9
  • [10] Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
    Hillarp, A.
    Baghaei, F.
    Blixter, I. Fagerberg
    Gustafsson, K. M.
    Stigendal, L.
    Sten-Linder, M.
    Strandberg, K.
    Lindahl, T. L.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (01) : 133 - 139